Clinical data | |
---|---|
Trade names | Dymelor |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a602021 |
ATC code | |
Pharmacokinetic data | |
Protein binding | 90% |
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.012.301 |
Chemical and physical data | |
Formula | C15H20N2O4S |
Molar mass | 324.395 g/mol |
3D model (Jmol) | |
|
|
|
|
Acetohexamide (trade name Dymelor) is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2, particularly in people whose diabetes cannot be controlled by diet alone.
Acetohexamide lowers blood sugar by stimulating the pancreas to secrete insulin and helping the body use insulin efficiently. The pancreas must produce insulin for this medication to work. For this reason, acetohexamide is not used to treat diabetes mellitus type 1.
Oral hypoglycemic drugs, including acetohexamide, have been associated with increased cardiovascular mortality. Talk to your doctor about the possible risks, benefits, and alternatives of using this drug for your condition.